Chargement en cours...
Glycoproteomics using so-called ‘fluid-biopsy’ specimens in the discovery of lung cancer biomarkers. Promise and challenge
Lung cancer is the number one cancer in the US and worldwide. In spite of the rapid progression in personalized treatments, the overall survival rate of lung cancer patients is still suboptimal. Over the past decade, tremendous efforts have been focused on the discovery of protein biomarkers to faci...
Enregistré dans:
| Publié dans: | Proteomics Clin Appl |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5079647/ https://ncbi.nlm.nih.gov/pubmed/23112109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prca.201200105 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|